In this cross-sectional study of adults hospitalized with respiratory syncytial virus (RSV) before the 2023 introduction of RSV vaccines, RSV was associated with substantial burden of hospitalizations ...
In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...
The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...
Compared with older adults hospitalized with influenza B, those hospitalized with respiratory syncytial virus (RSV) infection have a greater risk of dying within 90 days, according to a study ...
COVID-19 spreads from an infected person to others through respiratory droplets and aerosols ... People with COVID-19 can spread the virus to animals during close contact. To prevent possible ...
Public health experts are warning that the rising rates of RSV in the Southern U.S. could be a sign we need to prepare here in Southern California At one hospital in Texas, doctors are sounding the ...